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In-vivo evaluation of simultaneous administration of
incompatible drugs in a central venous catheter with a decreased
port to port distance
Gerardo Reyes, Gurpreet S Mander, Tarek S Husayni, Rabi F Sulayman and
David G Jaimovich
Background:  Multilumen catheters are commonly used in critically ill children.
Their use, however, is associated with significant morbidity. We studied the
simultaneous administration of incompatible drugs using a new triple-lumen
catheter with decreased length and port to port distances.
Methods: Ten domestic swine, 10–20kg in weight, were divided into two
groups of five. Total parenteral nutrition was administered through the distal port
and phenytoin was administered as a bolus and as an infusion in each group.
Samples were taken from two sites during the bolus and at 1, 5, and 15min
during phenytoin infusion. Histograms were generated for particle size and
concentration. Samples were also examined under the microscope for particles.
Results: Histograms of particle size did not show any alteration of the histogram
that would suggest particle size >2mm in diameter in the study or control
samples. No particles were identified by phase microscope, light microscope, or
Wright stain smear.
Conclusions: The use of a triple-lumen catheter with a distance of 0.4cm
between the proximal port and the medial port and 1.3cm between the medial
port and the distal port, for the in vivo simultaneous administration of
incompatible solutions does not result in precipitates large enough to cause
adverse clinical effects.
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Introduction
A multilumen central venous catheter is the preferred vas-
cular access route for critically ill patients requiring multi-
ple drug infusions, parenteral hyperalimentation, and
other potentially incompatible drugs [1]. The complexity
of delivering these substances becomes more difficult
when the size and length of the catheter is limited, as in
the pediatric population. A previous study has shown that
in vivo simultaneous intravenous infusion of physically
incompatible substances through a commercially available
multiple lumen intravenous catheter, double-lumen
peripheral venous catheter (IV-01100, Arrow Interna-
tional, Reading, Pennsylvania, USA) did not cause precip-
itation in the vascular system or other adverse clinical
effects [2].
This study looked at a modified 5.5F×5cm, triple-lumen
catheter with a port distance of 0.4cm between the medial
and proximal ports and 1.3cm between the distal and
medial ports (Arrow International), with a total distance of
1.7cm between the distal port and the proximal port, to
assess if decreased port spacing between lumens causes
precipitation when incompatible intravenous solutions are
administered simultaneously.
Materials and methods
Ten domestic swine weighing 10–20kg were anesthetized
with ketamine 10mg/kg intramuscularly, atropine
0.01mg/kg intravenously, and isoflurane for continuous
anesthesia. The trachea was intubated with a #5 or #6
uncuffed endotracheal tube and controlled ventilation was
instituted to maintain normal blood gases. A lead II elec-
trocardiogram was monitored continuously along with
temperature, respiration, and blood pressure. A peripheral
vein was isolated and cannulated for fluid and anesthetic
administration as necessary during the experiment. The
femoral veins in both hind limbs were isolated by the cut-
down technique. The experimental triple-lumen catheter,
with decreased port to port distances, was inserted into
the right femoral vein, and the control catheter was
Please note: This paper has not been approved for publication at presentinserted into the left femoral vein under direct visualiza-
tion. The control catheter was a 5.5F×5cm, triple-lumen
catheter with a standard port distance of 1.6cm between
the proximal and medial ports and 1.6cm between the
medial and distal ports respectively, for a total distance of
3.2cm between the distal port and the proximal port
(Arrow International). The size of the lumens is 20 gauge
for the distal lumen, and 22 gauge for the medial and prox-
imal lumens. Placement was confirmed by aspiration of
blood from all ports.
A midline incision was made, the peritoneum was identi-
fied, and the incision was extended to isolate and retract
peritoneal contents exposing the retroperitoneal vascula-
ture. The iliac vessels and the inferior vena cava were dis-
sected and isolated. Sampling sites were identified
immediately distal to the catheter tip and one catheter
length distal to the first sampling site. An 18-gauge
catheter with a three-way stop-cock was inserted at each
sampling site (Fig 1). Hematocrit was between 35% and
45% during the experiment.
Phenytoin and total parenteral nutrition (TPN) were
shown to be incompatible in vitro in a previous study [3].
A solution of phenytoin with a concentration of 50mg/ml
and pH12 as evaluated on a pH meter (255 Ph/ISE, CIBA
Corning Diagnostics, Oberlin, Ohio, USA) was adminis-
tered to all animals (n=10) through the distal lumen at the
usual maintenance dose of 2.5mg/kg/dose at a rate of
1mg/kg/min up to a maximum of 50mg/min via a syringe
infusion pump (1001, Medfusion Systems, Norcross,
Georgia, USA). The bolus was followed by a 3 ml normal
saline flush. The TPN solution (Table 1), with a pH of
5.8, was administered simultaneously through the medial
lumen at the standard clinical maintenance rate calculated
in ml/kg/day and divided over a 24-h period using the
same syringe infusion pump system. In the second phase
of the experiment, the same procedure described above
was performed with the phenytoin solution administered
through the medial lumen and the TPN administered
through the distal lumen. In the final phase, the pheny-
toin was administered through the proximal lumen and
the TPN through the medial lumen. The same methodol-
ogy was repeated on the opposite limb using the control
catheter.
Blood sampling was performed mid-way through the
phenytoin bolus administration, and at 1, 5, 10, and 15min
intervals for all ports of both catheters. Sampling was per-
formed simultaneously at both sampling sites; each
sample consisted of 1ml whole blood. Histograms were
generated by a coulter counter (Sysmex K-1000, Long
Grove, Illinois, USA) for particle size. Quality control on
the analyzer is performed on a real-time basis using com-
mercial controls once every 8-h shift on a daily basis
(Equinox 16T, Hematronix Inc., Benicia, California,
USA). All quality control data are handled according to
current College of American Pathologists’ standards. Cali-
bration of the analyzer is checked quarterly using a com-
mercial calibrator. Blinded specimens were examined
microscopically by phase microscope, light microscope,
and Wright stain smears.
The experimental protocol was reviewed and approved by
the animal care committee of our institution.
Results
Histograms for particle size, set with apertures for white
blood cells (24–300mm/100ml), red blood cells
(30–250mm/100ml) and platelets (2–20mm/100ml), did not
show any alteration of the histogram suggesting particle
size >2mm in diameter. At no point did any of the
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Table 1
The total parenteral nutrition solution
Amino acids 2.5%
Dextrose 10%
Intralipids 1.25%
NaCl 30mEq
KCl 10mEq
Ca gluconate 1000mEq
K2HPO4 5mEq
MVI-12 1ampule
MgSO4 200mg
Trace elements 5ml
Total volume 500ml
Figure 1
Peripheral multilumen catheter cutdown sites and proximal venous
blood sampling sites.samples, control or study, fail to pass a 2mm aperture.
Upon review of the white blood cells, red blood cells, and
platelet histograms generated by the hematology analyzer,
we could not identify any foreign particles in the animal
blood. We could not rule out the presence of particles in
very low concentrations, ie £3×10 3 particles/ml, which
would be the acceptable background count on this instru-
ment. No particles from various samples could be identi-
fied as examined by phase microscope, light microscope
and Wright stain smears in both control and study groups.
Mean heart rate, respirations, and temperature were
134±8 beat/min, 22±4 breath/min, and 38±0.7°C, respec-
tively.
Discussion
Central venous catheters in the pediatric population, and
especially in the pediatric intensive care setting, are com-
monly used for the administration of intravenous fluids,
drugs, chemotherapeutic agents, inotropic agents, and
hyperalimentation. Access to the intravascular space
includes the femoral, subclavian, and internal jugular
veins. The procedure is not without complications; these
include bleeding, venous thrombosis, vessel perforation,
sepsis, dysrhythmias, and catheter dislodgment or leakage,
among others [4–6]. Complications are relatively common
in the pediatric and neonatal population with a reported
incidence of 11.6% and 53% in two separate studies [7,8].
Leakage and extravasation of drugs and fluids can have
major consequences for the patient. Local edema, inflam-
mation, infection, and necrosis are the most serious com-
plications of fluid extravasation and may lead to tissue loss
requiring reconstructive surgery and, in some cases, may
cause loss of extremities. Dislodgment of the catheter can
also lead to the death of the patient [9].
A plausible reason for this high incidence of fluid extrava-
sation may be the distance between the proximal and
distal ports in commercially available multilumen pedi-
atric catheters. While the distal lumen may lie within the
intravascular space, the proximal lumen may be close to
the site of entry of the vein or even outside the vein. This
increases the possibility of extravasation if the catheter is
accidentally dislodged or is not sutured properly.
The new triple-lumen catheter, with decreased port to
port distances and shorter catheter length compared to
commercially available catheters, was developed for use in
the smallest possible patients. The shorter port to port dis-
tance and catheter length may help to minimize the
chance that one of the lumens might be positioned
improperly, resulting in the potential for extravascular
fluid infusion or catheter dislodgment.
Our findings are consistent with a previous study [2]
showing that the simultaneous infusion of phenytoin and
TPN solutions did not cause the precipitation of particles
large enough to be of clinical significance.
Conclusion
Using previously published methodology for the study of
the simultaneous administration of incompatible drugs via
a multiple lumen catheter, we conclude that the use of a
triple-lumen catheter with a port distance of 0.4cm
between the medial and proximal ports, 1.3cm between
the distal and medial ports, 1.7cm between the distal and
proximal lumens, and overall length of 5cm, for the in vivo
administration of incompatible solutions, phenytoin and
TPN, using a swine model, did not lead to precipitates
large enough to cause adverse clinical effects in our study.
This modified catheter was developed to minimize the
length of the catheter for use in the smallest possible
patients and to decrease the possibility that one of the
lumens might be positioned improperly, resulting in the
potential for extravasation of fluids or drugs.
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